Akari Therapeutics PLC (AKTX)

1.525 +0.04 (+3.04%) USD  |  NASDAQ  |  May 17, 16:00
1.525 0.00 (0.00%) After-Hours: 20:00
More

Akari Therapeutics EPS Estimates for Current Fiscal Year

EPS Estimates for Current Fiscal Year Chart

View EPS Estimates for Current Fiscal Year for AKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS Estimates for Current Fiscal Year Data

View and export this data back to 2021. Upgrade now.
Date Value
May 02, 2023 --
November 01, 2022 --
Date Value
April 23, 2021 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Current Fiscal Year Range, Past 5 Years

Upgrade
Minimum
Nov 01 2022
--
Maximum
Apr 23 2021
Upgrade
Average
Upgrade
Median
May 02 2023

EPS Estimates for Current Fiscal Year Benchmarks

DBV Technologies SA Upgrade
Cellectis SA Upgrade
Adaptimmune Therapeutics PLC Upgrade
Biodexa Pharmaceuticals Plc Upgrade
NuCana PLC Upgrade

EPS Estimates for Current Fiscal Year Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Next Fiscal Year Upgrade